Björkhem I
Biochim Biophys Acta. 1986 Jun 11;877(1):43-9. doi: 10.1016/0005-2760(86)90116-5.
The effect of treatment of rats with the hydroxymethylglutaryl-CoA reductase inhibitor, mevinolin, on 7 alpha-hydroxylation of cholesterol was studied. Treatment with 0.1% mevinolin in diet for 3 days was found to have an inhibitory effect on 7 alpha-hydroxylation of cholesterol (about 35%). Treatment with cholestyramine increased 7 alpha-hydroxylation of both exogenously added and endogenous microsomal cholesterol 3-4-fold. Combined treatment with both cholestyramine and mevinolin decreased this stimulation to 2-2.5-fold. Treatment with 2% cholesterol in diet increased 7 alpha-hydroxylation of exogenous cholesterol about 2-fold and 7 alpha-hydroxylation of endogenous cholesterol about 3.5-fold. The stimulatory effect of cholesterol was reduced or abolished when 0.1% mevinolin was added to the cholesterol-containing diet. With the exception of the experiments with cholesterol in the diet, all experiments including mevinolin gave a marked stimulation (up to 60-fold) of the hydroxymethylglutaryl-CoA reductase activity under the in vitro conditions employed. The concentration of free cholesterol in the liver microsomes was not significantly changed in any of these experiments. It is concluded that there is no coupling between induction of synthesis of hydroxymethylglutaryl-CoA reductase protein and cholesterol 7 alpha-hydroxylase activity. The inhibitory effect of mevinolin on cholesterol 7 alpha-hydroxylase activity under experimental conditions where most of the effect of mevinolin on hydroxymethylglutaryl-CoA reductase was abolished by treatment with cholesterol suggest that the effect of mevinolin on the cholesterol 7 alpha-hydroxylase may be independent of its effect on cholesterol synthesis. The over-all results do not favour the hypothesis that cholesterol synthesis and cholesterol availability are the most important determinants for the regulation of the cholesterol 7 alpha-hydroxylase.
研究了用羟甲基戊二酰辅酶A还原酶抑制剂美伐他汀治疗大鼠对胆固醇7α-羟化作用的影响。发现用0.1%美伐他汀饮食处理3天对胆固醇7α-羟化有抑制作用(约35%)。用消胆胺处理可使外源性添加的和内源性微粒体胆固醇的7α-羟化增加3 - 4倍。消胆胺与美伐他汀联合处理使这种刺激作用降至2 - 2.5倍。用2%胆固醇饮食处理可使外源性胆固醇的7α-羟化增加约2倍,内源性胆固醇的7α-羟化增加约3.5倍。当在含胆固醇饮食中添加0.1%美伐他汀时,胆固醇的刺激作用减弱或消失。除了饮食中含胆固醇的实验外,包括美伐他汀的所有实验在所用的体外条件下均使羟甲基戊二酰辅酶A还原酶活性有显著刺激(高达60倍)。在这些实验中,肝微粒体中游离胆固醇的浓度均无明显变化。结论是羟甲基戊二酰辅酶A还原酶蛋白合成的诱导与胆固醇7α-羟化酶活性之间没有偶联。在通过胆固醇处理消除了美伐他汀对羟甲基戊二酰辅酶A还原酶的大部分作用的实验条件下,美伐他汀对胆固醇7α-羟化酶活性的抑制作用表明,美伐他汀对胆固醇7α-羟化酶的作用可能与其对胆固醇合成的作用无关。总体结果不支持胆固醇合成和胆固醇可利用性是调节胆固醇7α-羟化酶的最重要决定因素这一假说。